Wellington Management Group LLP 13D and 13G filings for Nurix Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX |
Wellington Management Group LLP | 3,482,105 5.410% |
2,319,789 (+199.58%) |
Filing |
| 2022-02-04 09:21 am Sale |
2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Wellington Management Group LLP | 1,162,316 2.610% |
-1,285,268 (-52.51%) |
Filing |
| 2021-02-04 09:51 am Sale |
2020-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Wellington Management Group LLP | 2,447,584 6.300% |
-1,628,396 (-39.95%) |
Filing |
| 2020-08-10 09:43 am Purchase |
2020-07-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Wellington Management Group LLP | 4,075,980 10.780% |
4,075,980 (New Position) |
Filing |